![]()
|
Report Date : |
12.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
MEGA PRODUCTS CO LTD |
|
|
|
|
Registered Office : |
803 Monivong Boulevard , Khan Chamcarmon, Phnom
Penh |
|
|
|
|
Country : |
Cambodia |
|
|
|
|
Financials (as on) : |
31.12.2007 |
|
|
|
|
Date of Incorporation : |
21.05.1996 |
|
|
|
|
Legal Form : |
Private Limited Company
|
|
|
|
|
Line of Business : |
Importers Distributors Agents
Stockists and General Merchant of pharmaceutical products preparation
specialities and medical surgical clinical hospital equipment and supplies
laboratorychemical disposable products soft-gel capsules all sorts includes
vaccines injections and consumers products etc |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 150000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
MEGA PRODUCTS CO LTD
MEGA PRODUCTS (CAMBODIA) LTD
803 MONIVONG BOULEVARD
KHAN CHAMCARMON
PHNOM PENH CAMBODIA
AT HEADING ADDRESS
AT HEADING ADDRESS
Telephone [855-23] 212358 362712
987359
Telex NONE
Fax [855-23] 212359
IN SIHANOUK VILLE
IN PHNOM PENH [STORE AND WAREHOUSE]
21 05 1996
033 071-865 DATED 21 05 1996
PRIVATE LIMITED COMPANY
IMPORTERS DISTRIBUTORS AGENTS STOCKISTS AND GENERAL MERCHANT OF
PHARMACEUTICAL PRODUCTS PREPARATION SPECIALITIES AND MEDICAL SURGICAL CLINICAL
HOSPITAL EQUIPMENT AND SUPPLIES LABORATORYCHEMICAL DISPOSABLE PRODUCTS SOFT-GEL
CAPSULES ALL SORTS INCLUDES VACCINES INJECTIONS AND CONSUMERS PRODUCTS ETC
JIJI GEORGE - MANAGING DIRECTOR/COUNTRY CEO
SUISE HYUNH LIM
SOAK THAN KHI
MR MAHESH KUMAR YADAV - COUNTRY MANAGER
KIRIT C SHAH - CHAIRMAN
VIVEK DHAWAN - MANAGING DIRECTOR
PARAMJIT SINGH SAWHNEY
SUDHIR GANDHI
THOMAS ABRAHAM
CAMBODIAN COMMERCIAL BANK LTD PHNOM PENH
ANZ ROYAL BANK [CAMBODIA] LTD PHNOM PENH
PROMPT
VERY GOOD ADEQUATE RESOURCES AVAILABLE
G PREMJEE GROUP THAILAND 100% [NO FURTHER DETAILS PROVIDED]
G PREMJEE GROUP THAILAND MEDICAP LTD
MEDICAP LTD
REPUTED CO
PER 100% IRREVOCABLE AND CONFIRMED L/C AT SIGHT DRWAN BASIS
150000 CAN BE GRANTED ON MUTUAL AGREED SECURED AND PROTECTED TERM
WORLDWIDE
NONE
JANSSEN BELGIUM TAKEDA JAPAN B BRAUN GERMANY BOOTS UK J & J
USA
AS ABOVE
RENTED BASIS
80 +
OF A LOCAL CHAMBER OF COMMERCE AND OTHER TRADE ASSOCIATIONS
REPORT IS PRODUCED FROM COLLECTIVE RESULTS OF LOCAL AGENTS
SUBJECT IS CONSIDERED TO BE GOOD FOR ANY NORMAL BUSINESS
ENGAGEMENT
31 12 2007 IN KH RIEL / MILLION
PAIDUP 3000.00
RESERVE/SURPLUS 39051.85
DEFERRED LIABILITIES 28367.15
70419.00
CAPITAL SOURCES
FIXED ASSETS 25000.00
INVESTMENTS 9082.25
CURRENT ASSETS 58258.15
92340.40
LESS
CURRENT LIABILITIES 21921.40
70419.00
TURNOVER APPROX 90000.00
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)